The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase II study of ceralasertib (ATR inhibitor) plus durvalumab in patients with advanced gastric cancer (AGC) who progressed on prior anti-PD-(L)1 therapy.

Sung Hee  Lim

No Relationships to Disclose

Minae  An

No Relationships to Disclose

Ji Eun  Shin

No Relationships to Disclose

Minsuk  Kwon

Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Korea; MSD

Consulting or Advisory Role - Eisai

Research Funding - AstraZeneca

Seung Tae  Kim

No Relationships to Disclose

Jeeyun  Lee

No Relationships to Disclose